|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Trade accounts receivable | ||||||||||||||||||||
| Other accounts receivable | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Commodity derivatives contracts, net | ||||||||||||||||||||
| Commodity derivatives deposits | ||||||||||||||||||||
| Reimbursable costs | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment | ||||||||||||||||||||
| Less: accumulated depreciation | ||||||||||||||||||||
| Net property, plant and equipment | ||||||||||||||||||||
| Investments in non-controlled entities | ||||||||||||||||||||
| Right-of-use asset, operating leases | ||||||||||||||||||||
| Long-term receivables | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangibles (less accumulated amortization of $14.7 and $16.1 at December 31, 2022 and June 30, 2023, respectively) | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Noncurrent assets held for sale | ||||||||||||||||||||
| Other noncurrent assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND PARTNERS’ CAPITAL | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued payroll and benefits | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Accrued taxes other than income | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Accrued product liabilities | ||||||||||||||||||||
| Commodity derivatives contracts, net | ||||||||||||||||||||
| Commodity derivatives deposits | ||||||||||||||||||||
| Current portion of operating lease liability | ||||||||||||||||||||
| Liabilities held for sale | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, net | ||||||||||||||||||||
| Long-term operating lease liability | ||||||||||||||||||||
| Long-term pension and benefits | ||||||||||||||||||||
| Long-term liabilities held for sale | ||||||||||||||||||||
| Other noncurrent liabilities | ||||||||||||||||||||
| Partners’ capital: | ||||||||||||||||||||
| Common unitholders (203.0 units and 202.1 units outstanding at December 31, 2022 and June 30, 2023, respectively) | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total partners’ capital | ||||||||||||||||||||
| Total liabilities and partners’ capital | ||||||||||||||||||||
| Finite-Lived Intangible Assets, Accumulated Amortization | ||||||||||||||||||||
| Limited partner unitholders, units outstanding (in shares) | ||||||||||||||||||||
Loading...
